News on NOVENTURE participation at EAU 2019 in BARCELONA
For the fourth consecutive year, Noventure was present at the annual congress of the EAU - European Association of Urology- that took place in Barcelona 15th – 19th March 2019.
Noventure participation to EAU is to confirm its presence in the urology field with its medical device for oral use UTIPRO PLUS intended to control and prevent uncomplicated UTIs.
To welcome urologists from all over the world at the stand, with Noventure team, there were also the CEO and the Sales & Marketing Manager of ELVA Pharma, the Company distributing the product in Hungary and in the Czech and Slovak Republics, and one representative from the Marketing Team of Lapidot, the partner distributing Utipro Plus in Israel since 2017 some special thanks go to them for their contribution to the success of the event.
Utipro® Plus is a class III medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments. (CE 0373, Noventure SL)
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.